Zurcher Kantonalbank (Zurich Cantonalbank) - COLLPLANT BIOTECHNOLOGIES LT ownership

COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 20 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of COLLPLANT BIOTECHNOLOGIES LT
ValueSharesWeighting
Q3 2023$130,278
-30.7%
23,140
-0.1%
0.00%0.0%
Q2 2023$187,917
+15.8%
23,171
+0.2%
0.00%0.0%
Q1 2023$162,302
-16.2%
23,120
-0.3%
0.00%0.0%
Q4 2022$193,637
+21.8%
23,1900.0%0.00%0.0%
Q3 2022$159,000
-15.9%
23,190
-0.1%
0.00%0.0%
Q2 2022$189,000
-53.1%
23,210
-5.7%
0.00%
-50.0%
Q4 2021$403,00024,6230.00%
Other shareholders
COLLPLANT BIOTECHNOLOGIES LT shareholders Q2 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 577,909$4,056,9219.19%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 463,899$3,256,5710.62%
VILLERE ST DENIS J & CO LLC 289,797$2,034,3740.15%
BENJAMIN F. EDWARDS & COMPANY, INC. 65,911$4630.02%
Shay Capital LLC 10,000$70,2000.01%
SIMON QUICK ADVISORS, LLC 13,202$92,6780.01%
Zurcher Kantonalbank (Zurich Cantonalbank) 23,120$162,3020.00%
BROWN ADVISORY INC 73,849$518,4200.00%
Geneos Wealth Management Inc. 750$5,2650.00%
Focused Wealth Management, Inc 242$1,6990.00%
View complete list of COLLPLANT BIOTECHNOLOGIES LT shareholders